ACGL enters Tuesday's Q1 2026 earnings call at $97.06 with one data point that stands out sharply from the otherwise calm backdrop: options traders have been piling into puts at a rate well above their recent norm.
The put/call ratio has run between 2.5 and 3.4 for most of the last ten sessions — far above the 20-day average of 1.65. That reading peaked at 3.35 on April 27, the highest in the past year, before easing slightly to 2.52 on Tuesday. The stock is up roughly 4% over the past month and flat year-to-date at $97.06, so the elevated put demand cannot be attributed to a stock in freefall. Something is making options traders pay for downside protection specifically ahead of this print.
Short interest is not the source of pressure. At 1.8% of free float, short positioning is modest by any measure. It has climbed roughly 15% over the past week in share terms, but that brings the total from a low base to a still-low base. The borrow market is equally relaxed — cost to borrow is just 0.43%, and the lending pool remains ample, with availability wide open. There is no short-squeeze dynamic here, and bears are not crowding in via the stock loan market.
The Street's view is mixed but not alarmed. The mean analyst price target is $109, implying roughly 13% upside from current levels. JP Morgan trimmed its target to $110 from $117 on April 20 while keeping a Neutral rating, a modest pull-back that reflects some caution without a directional call. Barclays and Keefe, Bruyette & Woods each nudged their targets up modestly in early April. Bulls point to a reinsurance franchise that has scaled dramatically — gross written premiums in that unit grew from $1.9 billion in 2018 to over $11 billion in 2024 — along with rising investment income from higher global yields. Bears counter with harder evidence: a 13.5% year-over-year decline in property premiums in Q2 2025 and projections for nearly 25% deterioration in underwriting income by 2027 as pricing competition intensifies and the loss ratio drifts toward the low 60s. EPS surprise ranks in the 79th percentile historically, suggesting the company has a track record of beating estimates, but forward EPS momentum looks soft at the 38th percentile on a 30-day basis.
The one recent insider data point worth noting is directionally one-sided: the CEO and multiple senior executives sold a combined $9 million in shares during late February and early March, near prices around $96–$100. Those sales came at levels close to where the stock trades today. The print will test whether the bears' underwriting deterioration thesis is bearing out in the Q1 numbers, or whether Arch's diversification and investment income story is enough to offset the softening property cycle.
See the live data behind this article on ORTEX.
Open ACGL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
